Somatuline Autogel (lanreotide): Reviews and patient testimonials

/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1720004028

Medication indications

Somatuline Autogel 60mg, Somatuline Autogel 90mg, Somatuline Autogel 120mg

Somatuline Autogel is indicated for:

• The treatment of individuals with acromegaly when the circulating levels of Growth Hormone (GH) and/or Insulin-like Growth Factor-1 (IGF-1) remain abnormal after surgery and/or radiotherapy, or in patients who otherwise require medical treatment. The goal of treatment in acromegaly is to reduce GH and IGF-1 levels and where possible to normalise these values.

• The treatment of grade 1 and a subset of grade 2 (Ki67 index up to 10%) gastroenteropancreatic neuroendocrine tumours (GEP-NETs) of midgut, pancreatic or unknown origin where hindgut sites of origin have been excluded, in adult patients with unresectable locally advanced or metastatic disease.

• The treatment of symptoms associated with neuroendocrine (particularly carcinoid) tumours.


Molecule: lanreotide

Patients' opinions on Somatuline Autogel

In brief

General satisfaction level: 7.75/10 Learn more

Treatment's effectiveness: 9.25/10 Learn more

Ease of use: 5.50/10 Learn more

Adherence to prescription: 9.00/10 Learn more

Detected side effects: 6.00/10 Learn more

Improvement in the quality of life: 8.25/10 Learn more

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community


avatar
TheMagpie
on 02/09/2025

Although symptoms seem to be kept at bay by the drug the monthly injections are, to put it mildly, a pain in the a**e!

Your message

Members using this Somatuline Autogel

Conditions related to this medication

See the fact sheet
Fact sheet

Acromegaly

See the fact sheet